News

Intelligent Bio Solutions Expands Drug Testing Services in London

Intelligent Bio Solutions Expands Drug Testing Services in London

Intelligent Bio Solutions Expands Drug Testing Services in London

Intelligent Bio Solutions Inc. (Nasdaq: INBS), a pioneer in medical technology, has recently secured a transformative contract that enhances its drug testing services. This agreement involves one of London’s major public transport operators, impacting 14 operational sites and positively influencing the working conditions of over 4,400 staff members.

Boosting Safety and Efficiency

The deployment of INBS's cutting-edge Intelligent Fingerprinting Drug Screening System is set to revolutionize drug testing across a multi-garage bus network that caters to over one million passengers each day. With a fleet that includes more than 1,400 low-emission vehicles, comprising hybrid, electric, and hydrogen-powered buses, the initiative underscores a commitment to both safety and environmental responsibility.

The Insights from Leadership

Harry Simeonidis, President and CEO of Intelligent Bio Solutions, emphasized the significance of winning this contract. He stated, “Winning this tender says a lot about the strength of our technology. We offer a system that supports rapid drug testing at scale, reducing the downtime for employees and mitigating costs associated with long wait times.” His insights highlight the profound benefits that INBS provides, not just in efficiency but also in fostering a dignified approach to workplace safety.

Aligning with Modernization Efforts

The decision to implement INBS's drug testing solutions showcases the transport operator's ongoing investment in modern methods and the wellbeing of their employees. The cutting-edge engineering and logistics facilities complement their fleet and signify their forward-thinking approach in the transport sector.

Worldwide Reach and Growth Aspirations

Intelligent Bio Solutions is not just stopping at London. Their technology has already gained traction in 24 countries, supported by over 450 clients globally. They are keen on expanding further into the UK while also emphasizing growth in Europe, the Middle East, Africa, and Asia Pacific. A crucial part of their strategy includes obtaining regulatory clearance from the U.S. Food and Drug Administration (FDA), positioning them for entry into the U.S. market in the upcoming years.

Revolutionizing Drug Testing Technology

At the heart of Intelligent Bio Solutions’ offerings is their Intelligent Fingerprinting Drug Screening System, viewed as a game-changer in the field of portable testing. This innovative approach analyzes fingerprint sweat to provide quick and effective drug screenings for common workplace substances like opiates, cocaine, methamphetamine, and cannabis. With the collection process taking mere seconds and results being delivered in under ten minutes, this technology is truly designed for safety-critical industries.

Diverse Applications and Industries

The applications of INBS's technology extend beyond the transport sector. Their solutions are well-placed in industries including construction, manufacturing, engineering, and drug treatment organizations. This wide array of potential users showcases the versatility and adaptability of their product, making it an invaluable resource for employers striving to maintain safe and compliant working environments.

Company Overview

Intelligent Bio Solutions Inc. (NASDAQ: INBS) stands at the forefront of medical technology, focusing on delivering intelligent, rapid, and non-invasive testing solutions. With an innovative spirit and commitment to safety, the company is poised to revolutionize how drug testing is conducted globally.

Frequently Asked Questions

What is Intelligent Bio Solutions known for?

Intelligent Bio Solutions is recognized for its advanced medical technology, particularly its rapid, non-invasive drug testing solutions.

How does the Intelligent Fingerprinting System work?

The system analyzes fingerprint sweat to quickly screen for recent drug use, providing results in less than ten minutes.

Which industries benefit from INBS's technology?

Industries such as construction, manufacturing, transport, and drug treatment organizations use INBS's technology for workplace drug testing.

Where is INBS expanding its operations?

Intelligent Bio Solutions is expanding its operations in the UK and aims to enter markets in Europe, the Middle East, and the U.S.

Who can I contact for more information about INBS?

For further inquiries, you can contact Intelligent Bio Solutions Inc. at info@ibs.inc.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 0

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 173

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading